MK-8722, a broad-spectrum AMPK activator, demonstrates potent metabolic benefits but also induces reversible cardiac hypertrophy (48), likely due to non-selective activation of AMPKγ2, a subunit linked to hypertrophic signaling. Here, PRKAA2 is linked to cardiac hypertrophy.